SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-129488
Filing Date
2024-11-21
Accepted
2024-11-21 07:35:22
Documents
12
Period of Report
2024-11-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krro-20241121.htm   iXBRL 8-K 48070
2 EX-99.1 krro-ex99_1.htm EX-99.1 24510
  Complete submission text file 0000950170-24-129488.txt   233839

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT krro-20241121.xsd EX-101.SCH 54302
15 EXTRACTED XBRL INSTANCE DOCUMENT krro-20241121_htm.xml XML 5062
Mailing Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141
Business Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141 617-468-1999
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 241482186
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)